Engineering Coil-Coiled Domains for the Design of Modular Theranostic Agents: Galectin-3 as a Targeting Moiety.

Burgio C, Giron MD, Ortega-Muñoz M, Lucena D, Salto R.

Open source

DOI
10.1021/acs.biomac.6c00502
Published
2026-06-27
Container
Biomacromolecules
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.biomac.6c00502,
  title = {Engineering Coil-Coiled Domains for the Design of Modular Theranostic Agents: Galectin-3 as a Targeting Moiety.},
  author = {Burgio C and  Giron MD and  Ortega-Muñoz M and  Lucena D and  Salto R.},
  year = {2026},
  journal = {Biomacromolecules},
  doi = {10.1021/acs.biomac.6c00502},
  url = {https://doi.org/10.1021/acs.biomac.6c00502}
}

RIS

TY  - JOUR
TI  - Engineering Coil-Coiled Domains for the Design of Modular Theranostic Agents: Galectin-3 as a Targeting Moiety.
AU  - Burgio C
AU  -  Giron MD
AU  -  Ortega-Muñoz M
AU  -  Lucena D
AU  -  Salto R.
PY  - 2026
JO  - Biomacromolecules
DO  - 10.1021/acs.biomac.6c00502
UR  - https://doi.org/10.1021/acs.biomac.6c00502
ER  - 

APA

C, B., MD, G., M, O., D, L., & R., S. (2026). Engineering Coil-Coiled Domains for the Design of Modular Theranostic Agents: Galectin-3 as a Targeting Moiety.. Biomacromolecules. https://doi.org/10.1021/acs.biomac.6c00502

Source records